Literature DB >> 7018803

Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects.

P van Brummelen, F R Bühler, W Kiowski, F W Amann.   

Abstract

1. Changes in forearm blood flow to intra-arterial infusion of isoprenaline and the chronotropic response to intravenous boluses of isoprenaline were measured in 15 healthy volunteer subjects, eight younger than 25 years and seven older than 50 years. Intra-arterial blood pressure and basal plasma renin activity, adrenaline and noradrenaline were also measured. 2. Young subjects exhibited a greater increase in forearm blood flow than old subjects, to all four doses of isoprenaline used, a greater cardiac isoprenaline responsiveness (measured by the increase in heart rate; P less than 0.001) and a higher renin (P less than 0.02). 3. Resting values of blood pressure, forearm blood flow, adrenaline and noradrenaline were not significantly different in young and old subjects. In the latter, noradrenaline correlated with forearm blood flow (r = -0.77, P less than 0.05), forearm vascular resistance (r = 0.86, P less than 0.02) and mean arterial pressure (r = 0.83, P less than 0.02), whereas in the younger subjects forearm blood flow was related to adrenaline (r = 0.78, P less than 0.05). 4. These data provide evidence for an age-related parallel reduction in cardiac, peripheral vascular and renal beta-adrenoceptor-mediated responses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018803     DOI: 10.1042/cs0600571

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  27 in total

Review 1.  Nuclear cardiology approaches to defining normal and abnormal cardiovascular aging.

Authors:  J L Fleg; S P Schulman
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

2.  Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

3.  Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects.

Authors:  B J Lipworth; B F Tregaskis; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Impaired peripheral vasodilation during graded systemic hypoxia in healthy older adults: role of the sympathoadrenal system.

Authors:  Jennifer C Richards; Anne R Crecelius; Dennis G Larson; Gary J Luckasen; Frank A Dinenno
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-03       Impact factor: 4.733

Review 6.  Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.

Authors:  A Hämmerlein; H Derendorf; D T Lowenthal
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

7.  Beta-adrenoceptor responses to inhaled salbutamol in the elderly.

Authors:  B J Lipworth; B F Tregaskis; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 8.  Antihypertensive treatment according to age, plasma renin and race.

Authors:  F R Bühler
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

9.  Safety and cardiac chronotropic responsiveness to the early injection of atropine during dobutamine stress echocardiography in the elderly.

Authors:  J M Tsutsui; F Cerqueira Lario; D R Fernandes; I Kowatsch; J C Sbano; J A Franchini Ramires; W Mathias
Journal:  Heart       Date:  2005-03-29       Impact factor: 5.994

Review 10.  Physiological changes due to age. Implications for cardiovascular drug therapy.

Authors:  I Stolarek; P J Scott; F I Caird
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.